請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/23280完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 沈立言 | |
| dc.contributor.author | Hui-Chi Chang | en |
| dc.contributor.author | 張惠琦 | zh_TW |
| dc.date.accessioned | 2021-06-08T04:51:24Z | - |
| dc.date.copyright | 2009-07-30 | |
| dc.date.issued | 2009 | |
| dc.date.submitted | 2009-07-27 | |
| dc.identifier.citation | 1. 台灣十大死因統計資料。2007。行政院衛生署。
2. 台灣地區食品營養成份資料庫。2003。行政院衛生署食品衛生處。 3. 何岳峰。萱草根對於中樞神經系統之藥理學研究。1995。中國醫藥學院中國藥學研究所碩士論文。 4. 吳柏青。1998。農業推廣手冊（1）：金針產銷與加工流程。國立宜蘭技術學院農業推廣委員會。 5. 吳柏青。金針產業如何因應加入WTO之衝擊。2001。行政院農業委員會。 6. 林清華。精神藥物學 : 憂鬱症、焦慮症及失眠之治療。2005。合記出版社。 7. 周芳華。金針根部化學成分之研究。2001。中原大學化學研究所碩士論文。 8. 洪成志、鄭之雅。憂鬱症的動物模式。生物精神醫學暨神經精神藥理學通訊。2003。第一卷。台北榮總精神。 9. 施新獻。現代醫學實驗動物學。2000。北京人民軍醫出版社。 10. 徐蓮英、侯世祥。中藥製藥工藝技朮解析。2003。人民衛生出版社。 11. 莊金谷。金針產銷概況及展望。2006。農政與農情。 12. 許昇峰。憂鬱症中醫典籍彙編。2006。行政院衛生署中醫藥委員會。 13. 郭昭麟。常見藥用植物圖鑑。2006。行政院衛生署中醫藥委員會。 14. 陳珮茹。天麻水萃物的抗憂鬱效果。2008。國立臺灣大學生物資源暨農學院食品科技研究所博士論文。 15. 國家中醫藥管理局《中華本草》編委會。中華本草。1999。上海科學技術。 16. 國際疾病分類標準（ICD-10）。2005。行政院衛生署。 17. 梁雪君。萱草（Hemerocallis fulva L.）之成分研究。1994。中國醫藥學院藥物化學研究所碩士論文。 18. 曾玉如。推動低硫量「安全金針」企盼產業永續經營沈國周—太麻里金針產銷班班長。2008。行政院農業委員會。 19. 項平。中醫食療方全錄。1997。人民衛生出版社。 20. 黃宗正。情感疾病。In：實用精神醫學第二版；李明濱：國立台灣大學醫學院， 21. 2001；pp143-154。 22. 農糧署運銷加工組農產加工科。金針乾製品加工流程。2007。行政院農業委員會農糧署。 23. 農業統計年報。2007。行政院農業委員會。 24. 農業統計月報。2009年5月。行政院農業委員會。 25. 趙中振、蕭培根。當代藥用植物典。2006。香港賽馬會中藥研究有限公司。 26. 蔡文仁。金針產業在臺東。2001。農業世界。 27. 謝振偉、但德忠、趙 燕、周 娜。超聲波輔助萃取技術在樣品預處理中的應用。2005。化學通報年。 28. Afanas'ev, I. B.; Dorozhko, A. I.; Brodskii, A. V.; Kostyuk, V. A.; Potapovitch, A. I. Chelating and free radical scavenging mechanisms of inhibitory action of rutin and quercetin in lipid peroxidation. Biochem. Pharmacol. 1989, 38, 1763-1769. 29. Aguglia, E.; Casacchia, M.; Cassano, G.B.; Faravelli, C.; Ferrari, G.; Giordano, P.; Pancheri, P.; Ravizza, L.; Trabucchi, M. and Bolino, F. Double-blind study of the efficacy and safety of sertraline versus fluoxetine in major depression. Int. Clin. Psychopharmacol. 1993, 8, 197-202. 30. Aherne, S. A.; O'Brien, N. M. Mechanism of protection by the flavonoids, quercetin and rutin, against tert-butylhydroperoxide- and menadione-induced DNA single strand breaks in Caco-2 cells. Free Radic. Biol. Med. 2000, 29, 507-514. 31. Ali, M. S.; Mudagal, M. P.; Goli, D. Cardioprotective effect of tetrahydrocurcumin and rutin on lipid peroxides and antioxidants in experimentally induced myocardial infarction in rats. Pharmazie. 2009, 64, 132-136. 32. Anderson, I.M. Meta-analytical studies on new antidepressants. Br. Med. Bull. 2001. 57, 161-178. 33. Ara, I.; Bano, S. St. John's Wort modulates brain regional serotonin metabolism in swim stressed rats. Pak. J. Pharm. Sci. 2009, 22, 94-101. 34. Ashby, F. G.; Isen, A. M.; Turken, A. U. A neuropsychological theory of positive affect and its influence on cognition. Psychol. Rev. 1999, 106, 529-550. 35. Bach-Rojecky, L.; Kalodjera, Z.; Samarzija, I. The antidepressant activity of Hypericum perforatum L. measured by two experimental methods on mice. Acta. Pharm. 2004, 54, 157-162. 36. Bishnoi, M.; Chopra, K.; Kulkarni, S. K. Protective effect of rutin, a polyphenolic flavonoid against haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes. Fundam. Clin. Pharmacol. 2007, 21, 521-529. 37. Bliss, E. L.; Ailion, J.; Zwanziger, J. Metabolism of norepinephrine, serotonin and dopamine in rat brain with stress. J. Pharmacol. Exp. Ther. 1968, 164, 122-134. 38. Bor, J. Y.; Chen, H. Y.; Yen, G. C. Evaluation of antioxidant activity and inhibitory effect on nitric oxide production of some common vegetables. J. Agric. Food Chem. 2006, 54, 1680-1686. 39. Borsini, F.; Meli, A. Is the forced swimming test a suitable model for revealing antidepressant activity? Psychopharmacology (Berl.) 1988, 94, 147-160. 40. Bowley, M. P.; Drevets, W. C.; Ongur, D.; Price, J. L. Low glial numbers in the amygdala in major depressive disorder. Biol. Psychiatry 2002, 52, 404-412. 41. Boyle, S. P.; Dobson, V. L.; Duthie, S. J.; Hinselwood, D. C.; Kyle, J. A.; Collins, A. R. Bioavailability and efficiency of rutin as an antioxidant: a human supplementation study. Eur. J. Clin. Nutr. 2000, 54, 774-782. 42. Brambilla, P.; Cipriani, A.; Hotopf, M.; Barbui, C. Side-effect profile of fluoxetine in comparison with other SSRIs, tricyclic and newer antidepressants: a meta-analysis of clinical trial data. Pharmacopsychiatry 2005, 38, 69-77. 43. Bunney, W. E., Jr.; Davis, J. M. Norepinephrine in depressive reactions. Arch. Gen. Psychiatry 1965, 13, 483-494. 44. Butterweck, V.; Schmidt, M. St. John's wort: role of active compounds for its mechanism of action and efficacy. Wien. Med. Wochenschr. 2007, 157, 356-361. 45. Calapai, G.; Crupi, A.; Firenzuoli, F.; Costantino, G.; Inferrera, G.; Campo, G. M.; Caputi, A. P. Effects of Hypericum perforatum on levels of 5-hydroxytryptamine, noradrenaline and dopamine in the cortex, diencephalon and brainstem of the rat. J. Pharm. Pharmacol. 1999, 51, 723-728. 46. Campbell, S.; Macqueen, G. The role of the hippocampus in the pathophysiology of major depression. J. Psychiatry Neurosci. 2004, 29, 417-426. 47. Cheng, A. T. Mental illness and suicide. A case-control study in east Taiwan. Arch. Gen. Psychiatry 1995, 52, 594-603. 48. Cheng, F.C.; Kuo, J.S.; Shih, Y.; Lai, J.S.; Ni, D.R.; Chia, L.G. Simultaneous measurement of serotonin, catecholamines and their metabolites in mouse-brain homogenates by high-performance liquid-chromatography with a microbore column and dual electrochemical detection. J. Chromatogr. B. Biomed. 1993, Appl 615, 225-236. 49. Chen, P. J.; Hsieh, C. L.; Su, K. P.; Hou, Y. C.; Chiang, H. M.; Lin, I. H.; Sheen, L. Y. The antidepressant effect of Gastrodia elata Bl. on the forced-swimming test in rats. Am. J. Chin. Med. 2008, 36, 95-106. 50. Chimenti F, Cottiglia F, Bonsignore L, Casu L, Casu M, Floris C, Secci D, Bolasco A, Chimenti P, Granese A, Befani O, Turini P, Alcaro S, Ortuso F, Trombetta G, Loizzo A, Guarino I. Quercetin as the active principle of Hypericum hircinum exerts a selective inhibitory activity against MAO-A: extraction, biological analysis, and computational study. J. Nat. Prod. 2006, 69, 945-949. 51. Cichewicz, R. H.; Nair, M. G. Isolation and characterization of stelladerol, a new antioxidant naphthalene glycoside, and other antioxidant glycosides from edible daylily (hemerocallis) flowers. J. Agric. Food Chem. 2002, 50, 87-91. 52. Connor, T. J.; Kelliher, P.; Shen, Y.; Harkin, A.; Kelly, J. P.; Leonard, B. E. Effect of subchronic antidepressant treatments on behavioral, neurochemical, and endocrine changes in the forced-swim test. Pharmacol. Biochem. Behav. 2000, 65, 591-597. 53. Coppen, A. The biochemistry of affective disorders. Br. J. Psychiatry 1967, 113, 1237-1242 . 54. Couch, J. F.; Naghski, J.; Krewson, C. F. Buckwheat as a source of rutin. Science 1946, 103, 197-198. 55. Cruz, T.; Galvez, J.; Ocete, M. A.; Crespo, M. E.; Sanchez de Medina, L. H. F.; Zarzuelo, A. Oral administration of rutoside can ameliorate inflammatory bowel disease in rats. Life Sci. 1998, 62, 687-695. 56. Cryan, J. F.; Page, M. E.; Lucki, I. Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment. Psychopharmacology (Berl.) 2005, 182, 335-344. 57. Cryan, J. F.; Valentino, R. J.; Lucki, I. Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci. Biobehav. Rev. 2005, 29, 547-569. 58. Damier, P.; Kastner, A.; Agid, Y.; Hirsch, E. C. Does monoamine oxidase type B play a role in dopaminergic nerve cell death in Parkinson's disease? Neurology 1996, 46, 1262-1269. 59. Danila, A. M.; Kotani, A.; Hakamata, H.; Kusu, F. Determination of rutin, catechin, epicatechin, and epicatechin gallate in buckwheat Fagopyrum esculentum Moench by micro-high-performance liquid chromatography with electrochemical detection. J. Agric. Food Chem. 2007, 55, 1139-1143. 60. Delgado, P. L. Depression: the case for a monoamine deficiency. J. Clin. Psychiatry 2000, 61 Suppl 6, 7-11. 61. Delgado, P. L. How antidepressants help depression: mechanisms of action and clinical response. J. Clin. Psychiatry 2004, 65 Suppl 4, 25-30. 62. Detke, M.J.; Lucki, I. Detection of serotonergic and noradrenergic antidepressants in the rat forced swimming test: the effects of water depth. Behav. Brain Res. 1996, 73, 43–46. 63. Depression. 2009. NIMH. http://www.nimh.nih.gov/health/topics/depression/ 64. Depression. 2009. WHO. http://www.who.int/topics/depression/en/ 65. Dimpfel, W. Rat electropharmacograms of the flavonoids rutin and quercetin in comparison to those of moclobemide and clinically used reference drugs suggest antidepressive and/or neuroprotective action. Phytomedicine 2009, 16, 287-294. 66. Ding, S.; Dudley, E.; Plummer, S.; Tang, J.; Newton, R. P.; Brenton, A. G. Quantitative determination of major active components in Ginkgo biloba dietary supplements by liquid chromatography/mass spectrometry. Rapid Commun. Mass Spectrom. 2006, 20, 2753-2760. 67. Du, L.; Faludi, G.; Palkovits, M.; Sotonyi, P.; Bakish, D.; Hrdina, P. D. High activity-related allele of MAO-A gene associated with depressed suicide in males. Neuroreport 2002, 13, 1195-1198. 68. Fuller, R. W.; Wong, D. T. Inhibition of serotonin reuptake. Fed. Proc. 1977, 36, 2154-2158. 69. Fu, M.; Mao, L. In vitro antioxidant activities of five cultivars of daylily flowers from China. Nat. Prod. Res. 2008, 22, 584-591. 70. Glowinsk, J.; Iversen, L.L. Regional studies of catecholamines in rat brain. 1. Disposition of [3H]norepinephrine [3H]dopamine and [3H]dopa in various regions of brain. J. Neurochem. 1966, 13, 655-669. 71. Gobert, A.; Rivet, J.M.; Cistarelli, L.; Melon, C.; Millan, M.J. Alpha2-adrenergic receptor blockade markedly potentiates duloxetine- and fluoxetine-induced increases in noradrenaline, dopamine, and serotonin levels in the frontal cortex of freely moving rats. J. Neurochem. 1997, 69, 2616-2619. 72. Grinberg, L. N.; Rachmilewitz, E. A.; Newmark, H. Protective effects of rutin against hemoglobin oxidation. Biochem. Pharmacol. 1994, 48, 643-649. 73. Halford, J. C.; Harrold, J. A.; Boyland, E. J.; Lawton, C. L.; Blundell, J. E. Serotonergic drugs : effects on appetite expression and use for the treatment of obesity. Drugs 2007, 67, 27-55. 74. Hasumura, M.; Yasuhara, K.; Tamura, T.; Imai, T.; Mitsumori, K.; Hirose, M. Evaluation of the toxicity of enzymatically decomposed rutin with 13-weeks dietary administration to Wistar rats. Food Chem. Toxicol. 2004, 42, 439-444. 75. Higgins, E. S. The neuroscience of clinical psychiatry : the pathophysiology of behavior and mental illness. Wolters Kluwer Health/Lippincott Williams & Wilkins 2007. 76. Hirschfeld, R. M. History and evolution of the monoamine hypothesis of depression. J. Clin. Psychiatry 2000, 61 Suppl 6, 4-6. 77. Horhammer, L.; Muller, K. Occurrence of rutin in Rheum species. Arch. Pharm. Ber. Dtsch. Pharm. Ges. 1954, 287, 126-128. 78. Hsu, C. L.; Wu, C. H.; Huang, S. L.; Yen, G. C. Phenolic compounds rutin and o-coumaric acid ameliorate obesity induced by high-fat diet in rats. J. Agric. Food Chem. 2009, 57, 425-431. 79. International Statistical Classification of Diseases and Related Health Problems, 10th revision, 1994, World Health Organization. 80. Isabelle, M.; Lee, B. L.; Ong, C. N.; Liu, X.; Huang, D. Peroxyl radical scavenging capacity, polyphenolics, and lipophilic antioxidant profiles of mulberry fruits cultivated in southern China. J. Agric. Food Chem. 2008, 56, 9410-9416. 81. Jama, A.; Cecchi, M.; Calvo, N.; Watson, S. J.; Akil, H. Inter-individual differences in novelty-seeking behavior in rats predict differential responses to desipramine in the forced swim test. Psychopharmacology (Berl.) 2008, 198, 333-340. 82. Jung, M.; Park, M. Acetylcholinesterase inhibition by flavonoids from Agrimonia pilosa. Molecules 2007, 12, 2130-2139. 83. Kamalakkannan, N.; Stanely Mainzen Prince, P. Rutin improves the antioxidant status in streptozotocin-induced diabetic rat tissues. Mol. Cell. Biochem. 2006, 293, 211-219. 84. Kampkotter, A.; Nkwonkam, C. G.; Zurawski, R. F.; Timpel, C.; Chovolou, Y.; Watjen, W.; Kahl, R. Investigations of protective effects of the flavonoids quercetin and rutin on stress resistance in the model organism Caenorhabditis elegans. Toxicology 2007, 234, 113-123. 85. Karolewicz, B.; Paul, I. A.; Antkiewicz-Michaluk, L. Effect of NOS inhibitor on forced swim test and neurotransmitters turnover in the mouse brain. Pol. J. Pharmacol. 2001, 53, 587-596. 86. Kelliher, P.; Connor, T. J.; Harkin, A.; Sanchez, C.; Kelly, J. P.; Leonard, B. E. Varying responses to the rat forced-swim test under diurnal and nocturnal conditions. Physiol. Behav. 2000, 69, 531-539. 87. Khan, Aman U. Neurochemistry of schizophrenia & depression. A.J. Publisher 1998. 88. Kirby, L. G.; Allen, A. R.; Lucki, I. Regional differences in the effects of forced swimming on extracellular levels of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid. Brain Res. 1995, 682, 189-196. 89. Koda, T.; Kuroda, Y.; Imai, H. Rutin supplementation in the diet has protective effects against toxicant-induced hippocampal injury by suppression of microglial activation and pro-inflammatory cytokines : protective effect of rutin against toxicant-induced hippocampal injury. Cell Mol. Neurobiol. 2009. 90. La Casa, C.; Villegas, I.; Alarcon de la Lastra, C.; Motilva, V.; Martin Calero, M. J. Evidence for protective and antioxidant properties of rutin, a natural flavone, against ethanol induced gastric lesions. J. Ethnopharmacol. 2000, 71, 45-53. 91. Lee, M. H.; Lin, R. D.; Shen, L. Y.; Yang, L. L.; Yen, K. Y.; Hou, W. C. Monoamine oxidase B and free radical scavenging activities of natural flavonoids in Melastoma candidum D. Don. J. Agric. Food Chem. 2001, 49, 5551-5555. 92. Lopez-Rubalcava, C., Lucki, I. Strain differences in the behavioral effects of antidepressant drugs in the rat forced swimming test. Neuropsychopharmacology 2000, 22, 191–199. 93. Lucki, I. The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. Behav. Pharmacol. 1997, 8, 523-532. 94. Machado, D.G.; Bettio, L.E.; Cunha, M.P.; Santos, A.R.; Pizzolatti, M.G.; Brighente, I.M.; Rodrigues, A.L. Antidepressant-like effect of rutin isolated from the ethanolic extract from Schinus molle L. in mice: evidence for the involvement of the serotonergic and noradrenergic systems. Eur. J. Pharmacol. 2008, 587, 163-168. 95. Manach, C.; Morand, C.; Demigne, C.; Texier, O.; Regerat, F.; Remesy, C. Bioavailability of rutin and quercetin in rats. F. E. B. S. Lett. 1997, 409, 12-16. 96. Mayorga, A.J.; Dalvi, A.; Page, M.E.; Zimov-Levinson, S.; Hen, R.; Lucki, I. Antidepressant-like behavioral effects in 5-hydroxytryptamine1A and 5-hydroxytryptamine1B receptor mutant mice. J. Pharmacol. Exp. Ther. 2001, 298, 1101–1107. 97. Mazarati, A.; Siddarth, P.; Baldwin, R. A.; Shin, D.; Caplan, R.; Sankar, R. Depression after status epilepticus: behavioural and biochemical deficits and effects of fluoxetine. Brain 2008, 131, 2071-2083. 98. Mazzio, E. A.; Harris, N.; Soliman, K. F. Food constituents attenuate monoamine oxidase activity and peroxide levels in C6 astrocyte cells. Planta Med. 1998, 64, 603-606. 99. McGuirk, J.; Silverstone, T. The effect of the 5-HT re-uptake inhibitor fluoxetine on food intake and body weight in healthy male subjects. Int. J. Obes. 1990, 14, 361-372. 100. McKinney, W.T. Basis of development of animal models in psychiatry: an overview. In: Animal Models of Depression; Koob, G.F.; Ehlers, C.L.; Kupfer, D.J., Eds.; Birhäuser: Boston, 1989; pp. 3-17. 101. Michel, T. M.; Frangou, S.; Thiemeyer, D.; Camara, S.; Jecel, J.; Nara, K.; Brunklaus, A.; Zoechling, R.; Riederer, P. Evidence for oxidative stress in the frontal cortex in patients with recurrent depressive disorder--a postmortem study. Psychiatry Res. 2007, 151, 145-150. 102. Mitchell, R. L.; Phillips, L. H. The psychological, neurochemical and functional neuroanatomical mediators of the effects of positive and negative mood on executive functions. Neuropsychologia. 2007, 45, 617-629. 103. Nair, N. P.; Sharma, M. Neurochemical and receptor theories of depression. Psychiatr. J. Univ. Ott. 1989, 14, 328-341. 104. Noldner, M.; Schotz, K. Rutin is essential for the antidepressant activity of Hypericum perforatum extracts in the forced swimming test. Planta Med. 2002, 68, 577-580. 105. Nutt, D.; Demyttenaere, K.; Janka, Z.; Aarre, T.; Bourin, M.; Canonico, P. L.; Carrasco, J. L.; Stahl, S. The other face of depression, reduced positive affect: the role of catecholamines in causation and cure. J. Psychopharmacol. 2007, 21, 461-471. 106. Nutt, D. J. Relationship of neurotransmitters to the symptoms of major depressive disorder. J. Clin. Psychiatry 2008, 69 Suppl E1, 4-7. 107. Page, M. E.; Brown, K.; Lucki, I. Simultaneous analyses of the neurochemical and behavioral effects of the norepinephrine reuptake inhibitor reboxetine in a rat model of antidepressant action. Psychopharmacology (Berl.) 2003, 165, 194-201. 108. Page, M. E.; Detke, M. J.; Dalvi, A.; Kirby, L. G.; Lucki, I. Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test. Psychopharmacology (Berl.) 1999, 147, 162-167. 109. Park, H. H.; Lee, S.; Son, H. Y.; Park, S. B.; Kim, M. S.; Choi, E. J.; Singh, T. S.; Ha, J. H.; Lee, M. G.; Kim, J. E.; Hyun, M. C.; Kwon, T. K.; Kim, Y. H.; Kim, S. H. Flavonoids inhibit histamine release and expression of proinflammatory cytokines in mast cells. Arch. Pharm. Res. 2008, 31, 1303-1311. 110. Paulke, A.; Noldner, M.; Schubert-Zsilavecz, M.; Wurglics, M. St. John's wort flavonoids and their metabolites show antidepressant activity and accumulate in brain after multiple oral doses. Pharmazie. 2008, 63, 296-302. 111. Porsolt, R.D.; Anton, G.; Blavet, N.; Jalfre, M. Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur. J. Pharmacol. 1978a, 47, 379-391. 112. Porsolt, R.D.; Bertin, A.; Jalfre, M. Behavioral despair in mice: a primary screening test for antidepressants. Arch. Int. Pharmacodyn. Ther. 1977a, 229, 327-336. 113. Porsolt, R.D.; Bertin, A.; Jalfre, M. 'Behavioural despair' in rats and mice: strain differences and the effects of imipramine. Eur. J. Pharmacol. 1978b, 51, 291-294. 114. Porsolt, R.D.; Le Pichon, M.; Jalfre, M. Depression: a new animal model sensitive to antidepressant treatments. Nature 1977b, 266, 730-732. 115. Post, R. M.; Gordon, E. K. Wegener, G.; Bandpey, Z.; Heiberg, I. L.; Mork, A.; Rosenberg, R. Increased extracellular serotonin level in rat hippocampus induced by chronic citalopram is augmented by subchronic lithium: neurochemical and behavioural studies in the rat. Psychopharmacology (Berl.) 2003, 166, 188-194. 116. Pu, F.; Mishima, K.; Irie, K.; Motohashi, K.; Tanaka, Y.; Orito, K.; Egawa, T.; Kitamura, Y.; Egashira, N.; Iwasaki, K.; Fujiwara, M. Neuroprotective effects of quercetin and rutin on spatial memory impairment in an 8-arm radial maze task and neuronal death induced by repeated cerebral ischemia in rats. J. Pharmacol. Sci. 2007, 104, 329-334. 117. Que, F.; Mao, L.; Zheng, X. In vitro and vivo antioxidant activities of daylily flowers and the involvement of phenolic compounds. Asia Pac. J. Clin. Nutr. 2007, 16 Suppl 1, 196-203. 118. Randlov, C.; Mehlsen, J.; Thomsen, C. F.; Hedman, C.; von Fircks, H.; Winther, K. The efficacy of St. John's wort in patients with minor depressive symptoms or dysthymia--a double-blind placebo-controlled study. Phytomedicine 2006, 13, 215-221. 119. Redmond, D. E., Jr.; Katz, M. M.; Maas, J. W.; Swann, A.; Casper, R.; Davis, J. M. Cerebrospinal fluid amine metabolites. Relationships with behavioral measurements in depressed, manic, and healthy control subjects. Arch. Gen. Psychiatry 1986, 43, 938-947. 120. Redrobe, J.P.; Bourin, M. Colombel, M.C. Baker, G.B. Dose-dependent noradrenergic and serotonergic properties of venlafaxine in animal models indicative of antidepressant activity. Psychopharmacology 1998a, 138, 1–8. 121. Redrobe, J.P., Bourin, M., Colombel, M.C., Baker, G.B. Psychopharmacological profile of the selective serotonin reuptake inhibitor, paroxetine: implication of noradrenergic and serotonergic mechanisms. J. Psychopharmacol. 1998b, 12, 348–355. 122. Reinikainen, K. J.; Paljarvi, L.; Halonen, T.; Malminen, O.; Kosma, V. M.; Laakso, M.; Riekkinen, P. J. Dopaminergic system and monoamine oxidase-B activity in Alzheimer's disease. Neurobiol. Aging 1988, 9, 245-252. 123. Renard, C. E.; Dailly, E.; David, D. J.; Hascoet, M.; Bourin, M. Monoamine metabolism changes following the mouse forced swimming test but not the tail suspension test. Fundam. Clin. Pharmacol. 2003, 17, 449-455. 124. Romanik, G.; Gilgenast, E.; Przyjazny, A.; Kaminski, M. Techniques of preparing plant material for chromatographic separation and analysis. J. Biochem. Biophys. Methods 2007, 70, 253-261. 125. Sakakibara, H.; Yoshino, S.; Kawai, Y.; Terao, J. Antidepressant-like effect of onion (Allium cepa L.) powder in a rat behavioral model of depression. Biosci. Biotechnol. Biochem. 2008, 72, 94-100. 126. Schildkraut, J. J. The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am. J. Psychiatry 1965, 122, 509-522. 127. Sheu, J. R.; Hsiao, G.; Chou, P. H.; Shen, M. Y.; Chou, D. S. Mechanisms involved in the antiplatelet activity of rutin, a glycoside of the flavonol quercetin, in human platelets. J. Agric. Food Chem. 2004, 52, 4414-4418. 128. Shih, J. C.; Chen, K. MAO-A and -B gene knock-out mice exhibit distinctly different behavior. Neurobiology (Bp.) 1999, 7, 235-246. 129. Shih, J. C.; Chen, K.; Ridd, M. J. Role of MAO A and B in neurotransmitter metabolism and behavior. Pol. J. Pharmacol. 1999, 51, 25-29. 130. Stahl, S. M. Depression and bipolar disorder : Stahl's essential psychopharmacology. Eds.; Cambridge: New York, 2008. 131. Tai, C. Y.; Chen, B. H. Analysis and stability of carotenoids in the flowers of daylily (Hemerocallis disticha) as affected by various treatments. J. Agric. Food Chem. 2000, 48, 5962-5968. 132. Tata, D. A.; Marciano, V. A.; Anderson, B. J. Synapse loss from chronically elevated glucocorticoids: relationship to neuropil volume and cell number in hippocampal area CA3. J. Comp. Neurol. 2006, 498, 363-374. 133. Traskman, L.; Asberg, M.; Bertilsson, L.; Sjostrand, L. Monoamine metabolites in CSF and suicidal behavior. Arch. Gen. Psychiatry 1981, 38, 631-636. 134. Uezu, E. A philological and cxperirnental investigation of the effects of Hemerocallis as food in man and ddY mice. Bull. Coll. Educ. Unit. Ryukyrrs. 1997, 51, 231-238. 135. Uezu, E. Effects of Hemerocallis on sleep in mice. Psychiatry Clin. Neurosci. 1998, 52, 136-137. 136. Watson, D.; Clark, L. A.; Carey, G. Positive and negative affectivity and their relation to anxiety and depressive disorders. J. Abnorm. Psychol. 1988, 97, 346-353. 137. Weiss, J. M.; Bailey, W. H.; Pohorecky, L. A.; Korzeniowski, D.; Grillione, G. Stress-induced depression of motor activity correlates with regional changes in brain norepinephrine but not in dopamine. Neurochem. Res. 1980, 5, 9-22. 138. Woelk, H. Comparison of St John's wort and imipramine for treating depression: randomised controlled trial. B.M.J. 2000, 321, 536-539. 139. World Health Organization. The global burden of disease: 2004 update. WHO: Geneva, 2008. 140. Xia, X.; Cheng, G; Pan, Y.; Xia, Z.H.; Kong, L.D. Behavioral, neurochemical and neuroendocrine effects of the ethanolic extract from Curcuma longa L. in the mouse forced swimming test. J. Ethnopharmacol. 2007, 110, 356-363. 141. Yang, C. Y.; Hsiu, S. L.; Wen, K. C.; Lin, S. P.; Tsai, S. Y.; Hou, Y. C.; Lee, P. D. Bioavailability and metabolic pharmacokinetics of rutin and quercetin in rats. J. Food Drug Anal. 2005, 13, 244-250. 142. Zemlan, F. P.; Garver, D. L. Depression and antidepressant therapy: receptor dynamics. Prog. Neuropsychopharmacol. Biol. Psychiatry 1990, 14, 503-523. 143. Ziaee, A.; Zamansoltani, F.; Nassiri-Asl, M.; Abbasi, E. Effects of rutin on lipid profile in hypercholesterolaemic rats. Basic Clin. Pharmacol. Toxicol. 2009, 104, 253-258. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/23280 | - |
| dc.description.abstract | 根據2008年世界衛生組織（world health organization, WHO）最新的報告預估，憂鬱症將於2030年成為世界排名第一的高負擔疾病。雖然目前已研發出多種抗憂鬱藥物，但藥物治療卻伴隨著許多副作用，使病人的治療順從性不高。金針（Hemerocallis fulva L.），《說文解字》名為「忘憂」，《本草綱目》又名為「療愁」，顧名思義其為中國傳統食療之安神良方。近代研究發現，金針花具有極佳之抗氧化活性，且可幫助睡眠與增強記憶力；而其所含之重要黃酮類成分，芸香素（rutin）亦被發表具有抗憂鬱之功效。因此本研究以金針花乙醇萃取物及芸香素為素材，採用強迫游泳試驗及腦部單胺類神經傳導物質含量分析，來探討其抗憂鬱效果。結果顯示，不論是短期或是長期試驗，給予金針花乙醇萃取物與芸香素之組別在強迫游泳試驗中的不活動時間均明顯低於控制組，且游泳時間顯著性增加，掙扎時間則沒有統計差異（p < 0.05）。進一步分析單胺類神經傳導物質後發現，金針花乙醇萃取物及芸香素能有效增加腦部血清素、正腎上腺素與多巴胺的含量（p < 0.05）。尤其金針花乙醇萃取物對血清素的影響最為顯著，在長期試驗中，所有腦區均出現顯著增加的情形，其代謝速率更在杏仁核（40.0~60.7%）、海馬迴（30.0~47.9%）及紋狀體（18.3~40.7%）明顯降低，並以杏仁核之下降幅度最大。此外，根據攝食量及體重變化量之結果，發現金針花乙醇萃取物與芸香素並不會造成如fluoxetine所伴隨的副作用。綜合以上，證實金針花乙醇萃取物確實可透過調控血清素傳導系統達到抗憂鬱效果，並且不會造成食慾下降及體重減輕之副作用產生，而芸香素則為其重要的抗憂鬱活性成分。 | zh_TW |
| dc.description.abstract | According to the prediction of 2008 WHO report, depression will be the worldwide No. 1 high burden disease by the year 2030. Although various antidepressants are commercially available, the accompanied side effects are not good for therapeutic compliance. Hemerocallis fulva L., also known as daylily, is traditionally used for soothing in Chinese dietary therapy. Recent researches discovered that daylily flowers containing potent antioxidative activity, and is good for improving sleep and memory. Rutin, a key flavonoid in daylily flowers, is also characterized as a candidate for antidepressant. In this study we investigated the antidepressant effects of ethanol extract of daylily flowers and rutin by forced swimming test and brain neurotransmitter content analysis. Our results showed that in both short term and long term test, the experimental groups of daylily flowers extract and rutin exhibited significantly reduction of immobility time in forced swimming test, and increased swimming time compared with the control group but not struggling time (p < 0.05). Further analysis on monoamines indicated that the daylily flowers extract and rutin could increase the contents of serotonin, norepinephrine and dopamine in brain (p < 0.05). In long term test, the daylily flowers extract markedly increased serotonin in whole brain and reduced serotonin turnover rate in amygdala (40.0~60.7%), hippocampus (30.0~47.9%), and striatum (18.3~40.7%), especially in amygdala (p < 0.05). Additionally, we found that daylily flowers extract and rutin did not cause food intake disorder and body weight loss which are the side effects of fluoxetine. In conclusion, present data illustrated that ethanol extract of daylily flowers does have antidepressant like effects possibly via the regulation of serotonergic system and has no side effects of reduction in body weight and appetite. Moreover, rutin might be playing a very important role in the antidepressant like effects of ethanol extract of daylily flowers. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-08T04:51:24Z (GMT). No. of bitstreams: 1 ntu-98-R96641011-1.pdf: 2029655 bytes, checksum: da1b4e3f3afe64387ce923c822c998e5 (MD5) Previous issue date: 2009 | en |
| dc.description.tableofcontents | 中文摘要…I
英文摘要…II 目錄…III 表目錄…VI 圖目錄…VII 第一章、 前言…1 第二章、 文獻回顧…2 第一節、 憂鬱症…2 一、憂鬱症之研究重要性…2 二、憂鬱症之定義、診斷及症狀…4 三、憂鬱症的成因與單胺類神經傳導物質之作用…6 四、憂鬱症的藥物治療…11 五、抗憂鬱藥物之動物評估模式…13 第二節、金針花…15 一、簡介…15 二、金針花的栽培現況與加工技術…16 三、金針花之生理功效…20 四、金針花之化學組成…23 第三節、芸香素…28 一、簡介…28 二、芸香素之吸收與代謝…28 三、芸香素之副作用與毒性…29 四、芸香素之生理功效…29 第三章、研究目的…32 第四章、實驗架構…32 第一節、短期試驗架構…33 第二節、長期試驗架構…34 第五章、材料與方法…35 第一節、實驗材料…35 一、金針花…35 二、實驗藥品…35 三、實驗儀器設備…36 第二節、實驗方法…38 一、金針花乙醇萃取物之萃取方法…38 二、金針花乙醇萃取物之芸香素含量分析…40 三、樣品給予及動物飼養…40 四、強迫游泳試驗…44 五、腦部神經傳導物質含量分析…44 六、統計分析…45 第六章、實驗結果…46 第一節、金針花萃取結果…46 一、萃取率…46 二、金針花乙醇萃取物之芸香素含量分析…46 第二節、動物試驗結果…47 一、強迫游泳試驗結果…47 二、腦部神經傳導物質含量分析結果…48 三、動物攝食量及體重變化…50 第三節、結果圖表…51 第七章、討論…71 第一節、金針花萃取…71 第二節、強迫游泳試驗…73 第三節、腦部神經傳導物質含量分析…76 第四節、食慾及體重變化…80 第五節、芸香素之抗憂鬱效果綜合討論…81 第八章、 結論…83 第九章、 參考文獻…84 | |
| dc.language.iso | zh-TW | |
| dc.subject | 金針花 | zh_TW |
| dc.subject | 強迫游泳試驗 | zh_TW |
| dc.subject | 芸香素 | zh_TW |
| dc.subject | 憂鬱症 | zh_TW |
| dc.subject | 血清素 | zh_TW |
| dc.subject | daylily flowers | en |
| dc.subject | forced swimming test | en |
| dc.subject | rutin | en |
| dc.subject | depression | en |
| dc.subject | serotonin | en |
| dc.title | 以強迫游泳試驗探討金針花乙醇萃取物之抗憂鬱效果 | zh_TW |
| dc.title | The Antidepressant Effect of Ethanol Extract of Daylily Flowers Evaluated by Forced Swimming Test | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 97-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 謝慶良,蘇冠賓,黃士懿,江文章 | |
| dc.subject.keyword | 金針花,血清素,憂鬱症,芸香素,強迫游泳試驗, | zh_TW |
| dc.subject.keyword | daylily flowers,serotonin,depression,rutin,forced swimming test, | en |
| dc.relation.page | 98 | |
| dc.rights.note | 未授權 | |
| dc.date.accepted | 2009-07-27 | |
| dc.contributor.author-college | 生物資源暨農學院 | zh_TW |
| dc.contributor.author-dept | 食品科技研究所 | zh_TW |
| 顯示於系所單位： | 食品科技研究所 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-98-1.pdf 未授權公開取用 | 1.98 MB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。